Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02688621 · ClinicalTrials.gov registry record · NA

Internet Assisted Obesity Treatment Enhanced With Financial Incentives

A NA study of Obesity, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
418
Enrollment target
2
Study locations

NCT02688621: Completed NA study of Obesity, sponsored by University of Vermont.

NCT02688621 is a NA study of Obesity that has completed, run by University of Vermont. The registered enrollment target is 418 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (49% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02688621, a NA study of Obesity, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
418 participants
Enrollment target
2
Study locations

Study Summary

The investigators propose a randomized controlled trial to evaluate whether the addition of financial incentives to a high-quality, online behavioral weight loss intervention produces better weight losses than the online treatment alone.

Primary Outcome

Weight will be measured at baseline, 2, 6 months. Weight loss at 6 months will be calculated as kg lost from baseline.

Conditions Studied

Interventions

  • BEHAVIORAL Internet Only
  • BEHAVIORAL Internet + Incentives

Study Locations (2)

South Carolina

  • University of South Carolina - Columbia

Vermont

  • Behavioral Weight Management Program/Univ of Vermont - Burlington

Trial Details

FieldValue
Enrollment Target 418 participants
Start Date 2016-04-11
Est. Completion 2019-08-02
Phase NA
University of Vermont

162 total trials

What the finished NCT02688621 record still lists

NCT02688621 is an interventional study that assigns participants to a tested intervention. The registered 418 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (49% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Internet Only is the first listed.

NCT02688621 reports a single indexed study location in South Carolina, Vermont.

Frequently Asked Questions

What is clinical trial NCT02688621 about?

NCT02688621 is a clinical study titled "Internet Assisted Obesity Treatment Enhanced With Financial Incentives". The investigators propose a randomized controlled trial to evaluate whether the addition of financial incentives to a high-quality, online behavioral weight loss intervention produces better weight losses than the online treatment alone.

What is the current status of trial NCT02688621?

This trial is currently completed. It is a NA study. The enrollment target is 418 participants. The study started on 2016-04-11. Estimated completion is 2019-08-02.

What conditions does trial NCT02688621 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02688621?

The interventions under investigation include: Internet Only (BEHAVIORAL), Internet + Incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT02688621?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02688621 being conducted?

This trial has 2 study locations across South Carolina, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02688621's enrollment target sits among peer trials

418 162nd of 1053 higher than 892 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03135886 · 418 participants · NA

    Project I Test: Implementing HIV Testing in Opioid Treatment Programs

  • NCT05579639 · 419 participants · Phase 2

    Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant

  • NCT06169735 · 417 participants · Phase 4

    Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation

  • NCT06699901 · 417 participants

    Antibiotic Concentrations After MassivE Transfusion Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02688621, the US trial registry maintained by the National Library of Medicine. NCT02688621 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.